Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-24

Clinical Trial Update: Memantine and Naltrexone Treatment for Opioid Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine in combination with naltrexone for opioid dependence; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Dependence | Phase 2 | Status: COMPLETED | Results posted: 2013-01-24